RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.ukCooper, Jamie2025-10-232023-05-06RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk & Cooper, J 2023, 'Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY) : a randomised, controlled, open-label, platform trial', Lancet (London, England), vol. 401, no. 10387, pp. 1499-1507. https://doi.org/10.1016/S0140-6736(23)00510-X0140-6736PubMedCentral: PMC10156147ORCID: /0000-0003-3812-7026/work/195319971https://hdl.handle.net/2164/26273We thank the thousands of patients who participated in this trial and the many doctors, nurses, pharmacists, and other allied health professionals. We would also like to thank research administrators at participating hospital organisations supported in the UK by staff at the National Institute of Health and Care Research (NIHR) Clinical Research Network, NHS DigiTrials, Public Health England, Department of Health and Social Care, the Intensive Care National Audit and Research Centre, Public Health Scotland, National Records Service of Scotland, the Secure Anonymised Information Linkage (SAIL) at University of Swansea, and the National Health Service in England, Scotland, Wales, and Northern Ireland.91090365engSDG 3 - Good Health and Well-beingAdultHumansMaleFemaleCOVID-19SARS-CoV-2HospitalsOxygenHypoxia/etiologyAdrenal Cortex Hormones/therapeutic useDexamethasone/therapeutic useTreatment OutcomeR Medicine (General)Supplementary DataDASR1Journal article10.1016/S0140-6736(23)00510-X